相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
David Cook et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Descriptive epidemiology of sarcomas in Europe: Report from the RARECARE project
C. A. Stiller et al.
EUROPEAN JOURNAL OF CANCER (2013)
Clinical Trials in Rare Disease: Challenges and Opportunities
Erika F. Augustine et al.
JOURNAL OF CHILD NEUROLOGY (2013)
Insulin Growth Factor-Receptor (IGF-1R) Antibody Cixutumumab Combined with the mTOR Inhibitor Temsirolimus in Patients with Refractory Ewing's Sarcoma Family Tumors
Aung Naing et al.
CLINICAL CANCER RESEARCH (2012)
Phase II Study of Ganitumab, a Fully Human Anti-Type-1 Insulin-Like Growth Factor Receptor Antibody, in Patients With Metastatic Ewing Family Tumors or Desmoplastic Small Round Cell Tumors
William D. Tap et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study
Alberto S. Pappo et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Randomized Phase II Study of Erlotinib in Combination With Placebo or R1507, a Monoclonal Antibody to Insulin-Like Growth Factor-1 Receptor, for Advanced-Stage Non-Small-Cell Lung Cancer
Suresh S. Ramalingam et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Preliminary Efficacy of the Anti-Insulin-Like Growth Factor Type 1 Receptor Antibody Figitumumab in Patients With Refractory Ewing Sarcoma
Heribert Juergens et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Adaptive group sequential design for phase II clinical trials: A Bayesian decision theoretic approach
Yiyi Chen et al.
STATISTICS IN MEDICINE (2009)
Bayesian sample size for exploratory clinical trials incorporating historical data
John Whitehead et al.
STATISTICS IN MEDICINE (2008)
Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling
Ultan McDermott et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Strategy for randomised clinical trials in rare cancers
SB Tan et al.
BRITISH MEDICAL JOURNAL (2003)